Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
A Phase I Trial of Tecogalan sodium (DS-4152) Administered as an Infusion Every 21 Days Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on A Phase I Trial of Tecogalan sodium (DS-4152) Administered as an Infusion Every 21 Days conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. A Phase I Trial of Tecogalan sodium (DS-4152) Administered as an Infusion Every 21 Days Clinical research trials and A Phase I Trial of Tecogalan sodium (DS-4152) Administered as an Infusion Every 21 Days healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including A Phase I Trial of Tecogalan sodium (DS-4152) Administered as an Infusion Every 21 Days. A Phase I Trial of Tecogalan sodium (DS-4152) Administered as an Infusion Every 21 Days Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a A Phase I Trial of Tecogalan sodium (DS-4152) Administered as an Infusion Every 21 Days clinical trial. Test subjects oftentimes recieve the best healthcare possible for their A Phase I Trial of Tecogalan sodium (DS-4152) Administered as an Infusion Every 21 Days condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "A" Clinical Trials Conditions > A Phase I Trial of Tecogalan sodium (DS-4152) Administered as an Infusion Every 21 Days

A Phase I Trial of Tecogalan sodium (DS-4152) Administered as an Infusion Every 21 Days



A Phase I Trial of Tecogalan sodium (DS-4152) Administered as an Infusion Every 21 Days

For Condition: Sarcoma, Kaposi,HIV Infections
Status: Completed
Sponsor(s): Daiichi Pharmaceuticals ,
Synopsis: To evaluate the safety of different doses and dosing regimens of tecogalan sodium (DS-4152) and to establish the MTD at each of the different dosing schedules.
Details: Patients receive intravenous DS-4152 by infusion once every 21 days; courses may repeat. Patients undergo weekly follow-up. A punch biopsy will be obtained from patients with Kaposi's sarcoma.
Eligibility:
Study Type:  Interventional, Treatment, Dose Comparison, Safety Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: - Kaposi's sarcoma plus HIV infection OR metastatic solid tumor. - Life expectancy of at least 12 weeks. - NO symptomatic AIDS-defining opportunistic infection within the past 4 weeks. - Recovered from toxicity of any prior anticancer therapy. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: - Leukemia or lymphoma. - Current gastrointestinal bleeding by stool guaiac. - Extensive bone metastases or significant radiographic osteoporosis in patients with solid tumors. - Active heart disease such as uncontrolled angina, uncompensated congestive heart failure, or dysrhythmias requiring antiarrhythmics. - Acute intercurrent infection other than genital herpes. - Symptomatic or known central nervous system involvement (including brain metastases) unless stable and off therapy. Concurrent Medication: Excluded: - Other anticancer therapy. - Other investigational agents. Patients with the following prior conditions are excluded: - History of acute or chronic gastrointestinal bleeding or inflammatory bowel disease. - History of myocardial infarction within past 6 months. Prior Medication: Excluded: - Anticancer therapy within the past 3 weeks (6 weeks for nitrosourea or mitomycin C). - Investigational agents within the past 4 weeks.
Total Enrollment: 

Location and Contact Information:

Cancer Therapy Research Ctr
San Antonio,  Texas,  78229
United States
 


Additional Information:
Study ID Numbers:  088A;  4152A-PRT001
Study Start Date: 
Record last reviewed: April 1996
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002136

Other Sarcoma, Kaposi Studies:
1. A Study of Patients with AIDS Syndrome

2. A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma

3. Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma

4. A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma

5. Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma

Related Studies:

Other Sarcoma, Kaposi Clinical Trials
Other Texas Clinical Trials
Other San Antonio Clinical Trials

A Phase I Trial of Tecogalan sodium (DS-4152) Administered as an Infusion Every 21 Days
Modify your Search

  Other Sarcoma, Kaposi Clinical Trials
  Other Texas Clinical Trials
  Other San Antonio Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103